Overall, and from a short-term perspective, the company presents an interesting fundamental situation.
Strengths
The earnings growth currently anticipated by analysts for the coming years is particularly strong.
The equity is one of the most attractive in the market with regard to earnings multiple-based valuation.
The company's share price in relation to its net book value makes it look relatively cheap.
Given the positive cash flows generated by its business, the company's valuation level is an asset.
The company is one of the best yield companies with high dividend expectations.
Analysts covering this company mostly recommend stock overweighting or purchase.
The difference between current prices and the average target price is rather important and implies a significant appreciation potential for the stock.
The opinion of analysts covering the stock has improved over the past four months.
Consensus analysts have strongly revised their opinion of the company over the past 12 months.
Weaknesses
The company does not generate enough profits, which is an alarming weak point.
The company is in a hindered financial situation with significant debt and rather low EBITDA levels.
For the last twelve months, sales expectations have been significantly downgraded, which means that less important sales volumes are expected for the current fiscal year over the previous period.
The sales outlook for the group was lowered in the last twelve months. This change in forecast points out a decline in activity as well as pessimistic analyses of the company.
For the last 12 months, analysts have been regularly downgrading their EPS expectations. Analysts predict worse results for the company against their predictions a year ago.